Novartis AG Operating Income 2012-2026 | NVS

Novartis AG operating income for the twelve months ending March 31, 2026 was $17.216B, a 8.73% increase year-over-year.

  • Novartis AG annual operating income for 2025 was $17.644B, a 21.31% increase from 2024.
  • Novartis AG annual operating income for 2024 was $14.544B, a 48.88% increase from 2023.
  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.

Novartis AG Operating Income 2012-2026 | NVS

  • Novartis AG annual operating income for 2025 was $17.644B, a 21.31% increase from 2024.
  • Novartis AG annual operating income for 2024 was $14.544B, a 48.88% increase from 2023.
  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B